SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-115928
Filing Date
2024-04-26
Accepted
2024-04-26 08:30:49
Documents
5
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d797640ddef14a.htm DEF 14A 671869
2 GRAPHIC g797640dsp64.jpg GRAPHIC 3973
3 GRAPHIC g797640g00a10.jpg GRAPHIC 125271
4 GRAPHIC g797640g00a11.jpg GRAPHIC 84996
5 GRAPHIC g797640g53e52.jpg GRAPHIC 28306
  Complete submission text file 0001193125-24-115928.txt   1004735
Mailing Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36483 | Film No.: 24878991
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)